Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Zalcitabine

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    U.S. Patent Office Issues Trethera Composition of Matter Patent Covering TRE-515
    U.S. Patent Office Issues Trethera Composition of Matter Patent Covering TRE-515

    20 Sep 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/09/20/2519592/0/en/U-S-Patent-Office-Issues-Trethera-Composition-of-Matter-Patent-Covering-TRE-515-Extending-Market-Exclusivity-to-Late-2041.html

    GLOBENEWSWIRE
    20 Sep 2022
    Share Share
    EMD Serono Continues Leadership Role in Product Integrity by Launching Product Tracking Program and Check My Meds™ Smartphone App
    EMD Serono Continues Leadership Role in Product Integrity by Launching Product Tracking Program and Check My Meds™ Smartphone App

    10 Dec 2014

    // Press Release PRNewswire

    http://www.prnewswire.com/news-releases/emd-serono-continues-leadership-role-in-product-integrity-by-launching-product-tracking-program-and-check-my-meds-smartphone-app-300007010.html

    Press Release PRNewswire
    10 Dec 2014
    Share Share
    Cystic Fibrosis Foundation Therapeutics Announces $15 Million Research Collaboration with Shire for Development of Novel CF Treatment
    Cystic Fibrosis Foundation Therapeutics Announces $15 Million Research Collaboration with Shire for Development of Novel CF Treatment

    10 Dec 2014

    // Press Release PRNewswire

    http://www.prnewswire.com/news-releases/cystic-fibrosis-foundation-therapeutics-announces-15-million-research-collaboration-with-shire-for-development-of-novel-cf-treatment-300007540.html

    Press Release PRNewswire
    10 Dec 2014
    Share Share